Inspiration Hlt Regulatory News (IHC)

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

Trading Update

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company today provides a trading update, in light of the economic and social disruption caused by the COVID-19 pandemic. 

Trading Update as at 30th April 2020

The Group has enjoyed very strong trading in the first quarter of its financial year with revenues up by 27% on the comparative period last year. This increase in revenues does not include the contracts won for the supply of ventilators to the UK National Health Service announced on the 16th and 20th March 2020 which, when combined, are worth over £5 million of additional revenue and are expected to be accounted for in the second quarter of the financial year. Without these exceptional orders, the Company's order book remains strong and the Company is receiving considerable interest in its products.

Neil Campbell, Chief Executive Officer of Inspiration Healthcare commented: "I am delighted with our performance so far this year; it positions us very well for continued growth. The current situation has presented challenges for many companies and it is a tribute to our team, along with our outstanding suppliers, that we are still supplying vital intensive care equipment and the support that goes with its use. We look forward to shipping the ventilators we have orders for to the NHS and to the rest of the year with confidence."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries:

About Inspiration Healthcare http://www.inspiration-healthcare.com

Inspiration Healthcare is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe. In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance. Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com